TWINSTRAND BIOSCIENCES INC.

In News

Guardant Can Try Again To Nix Patent Tied To $83M Verdict - Law360

Law360 - Jan 23, 2026

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology - PR Newswire

PR Newswire - Jul 31, 2024

Guardant Health hit with $83M verdict in TwinStrand DNA sequencing patent lawsuit - Fierce Biotech

Fierce Biotech - Nov 15, 2023

Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis - AJMC

AJMC - Dec 18, 2020

Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents - PR Newswire

PR Newswire - Nov 15, 2023

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says - Reuters

Reuters - Nov 15, 2023

TwinStrand names Ron Andrews as permanent CEO after 2022 leadership shuffle - The Business Journals

The Business Journals - Aug 29, 2023

Seattle top biotechs 2025: the 9 companies you should now about - Labiotech.eu

Labiotech.eu - Mar 13, 2025

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

Former Fred Hutch president joins board of TwinStrand Biosciences - The Business Journals

The Business Journals - Jan 08, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment